Angelalign Surges Over 16% After Profit Alert, Expects 69% to 78.9% Net Profit Growth in First Half

Deep News08-03

Angelalign (06699) shares surged over 16% following a profit alert, trading 15.90% higher at HK$92.60 as of the latest update, with turnover reaching HK$53.7608 million.

On July 31, Angelalign (06699) announced that for the first half of 2026, the group expects to achieve total revenue of approximately US$229 million to US$231 million, representing a year-on-year increase of 41.9% to 43.1%. Net profit is projected to be around US$24 million to US$25.4 million, up 69.0% to 78.9% compared to the same period last year.

The total number of invisible orthodontic cases reached approximately 316,600, a 40.2% increase year-on-year. Among these, cases in the global market (excluding Mainland China) grew by 43.3% to about 168,000, while cases in the Mainland China market rose by approximately 36.8% to around 148,600.

The board attributes the expected improvement in the group's performance to several factors: doctors across global and domestic markets at all levels are increasingly adopting invisible orthodontic systems with stable clinical efficacy, allowing the group to benefit continuously. Additionally, the professional brand and international direct sales and service network, which were heavily invested in over previous years, are beginning to unlock operational leverage, enhancing profitability. Furthermore, an open management culture that integrates multinational technical talent and clinical knowledge is accelerating product and service innovation.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment